Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D London

Showing results (341-350 of 590) with videos related to

Pageof 59
Sort By:
Stroke|November 1, 1996
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in ratsH Takahashi, J R Kirsch, K Hashimoto, et al.
Synapse (New York, N.Y.)|June 9, 2009
Laterality of cortical response to ethanol is moderated by TaqIA A1 alleleSteven M Berman, Ernest P Noble, Parvaneh Mohammadian, et al.
Scientific Reports|April 6, 2019
Baseline impulsivity may moderate L-DOPA effects on value-based decision-makingJohannes Petzold, Annika Kienast, Ying Lee, et al.
Stroke|November 6, 1998
Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivoA Bhardwaj, M Sawada, E D London, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2016
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine DependenceKyoji Okita, Nicole Petersen, Chelsea L Robertson, et al.
European Journal of Pharmacology|November 21, 1998
Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probeP M Sánchez-Roa, H N Wagner, V L Villemagne, et al.
Stroke|September 1, 1995
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in catsH Takahashi, J R Kirsch, K Hashimoto, et al.
Cellular Immunology|May 1, 1996
Respiratory-mucosal lymphocyte populations induced by reovirus serotype 1 infectionA H Thompson, L London, S C Bellum, et al.
Psychopharmacology|April 16, 2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
The American Journal of Drug and Alcohol Abuse|June 21, 2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
Pageof 59

Showing results (341-350 of 590) with videos related to

Sort By:
Pageof 59
Stroke|November 1, 1996
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in ratsH Takahashi, J R Kirsch, K Hashimoto, et al.
Synapse (New York, N.Y.)|June 9, 2009
Laterality of cortical response to ethanol is moderated by TaqIA A1 alleleSteven M Berman, Ernest P Noble, Parvaneh Mohammadian, et al.
Scientific Reports|April 6, 2019
Baseline impulsivity may moderate L-DOPA effects on value-based decision-makingJohannes Petzold, Annika Kienast, Ying Lee, et al.
Stroke|November 6, 1998
Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivoA Bhardwaj, M Sawada, E D London, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2016
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine DependenceKyoji Okita, Nicole Petersen, Chelsea L Robertson, et al.
European Journal of Pharmacology|November 21, 1998
Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probeP M Sánchez-Roa, H N Wagner, V L Villemagne, et al.
Stroke|September 1, 1995
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in catsH Takahashi, J R Kirsch, K Hashimoto, et al.
Cellular Immunology|May 1, 1996
Respiratory-mucosal lymphocyte populations induced by reovirus serotype 1 infectionA H Thompson, L London, S C Bellum, et al.
Psychopharmacology|April 16, 2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
The American Journal of Drug and Alcohol Abuse|June 21, 2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
Pageof 59